These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15856402)

  • 1. Dietary phytoestrogens: potential selective estrogen enzyme modulators?
    Basly JP; Lavier MC
    Planta Med; 2005 Apr; 71(4):287-94. PubMed ID: 15856402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells.
    Brooks JD; Thompson LU
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):461-7. PubMed ID: 15876411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.
    Aka JA; Mazumdar M; Lin SX
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):183-90. PubMed ID: 19038308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells.
    Matsumura A; Ghosh A; Pope GS; Darbre PD
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):431-43. PubMed ID: 15876408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy?
    Beck V; Rohr U; Jungbauer A
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):499-518. PubMed ID: 15876415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early life and adult exposure to isoflavones and breast cancer risk.
    Tomar RS; Shiao R
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(2):113-73. PubMed ID: 18569328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenylated isoflavonoids from plants as selective estrogen receptor modulators (phytoSERMs).
    Simons R; Gruppen H; Bovee TF; Verbruggen MA; Vincken JP
    Food Funct; 2012 Aug; 3(8):810-27. PubMed ID: 22684228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of breast cancer.
    Castrellon AB; Glück S
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):443-52. PubMed ID: 18366291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of dietary phytoestrogens on aromatase activity in human endometrial stromal cells.
    Edmunds KM; Holloway AC; Crankshaw DJ; Agarwal SK; Foster WG
    Reprod Nutr Dev; 2005; 45(6):709-20. PubMed ID: 16285913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17beta-hydroxysteroid dehydrogenases in human breast cancer.
    Nagasaki S; Miki Y; Akahira J; Suzuki T; Sasano H
    Ann N Y Acad Sci; 2009 Feb; 1155():25-32. PubMed ID: 19250189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know.
    Velentzis LS; Woodside JV; Cantwell MM; Leathem AJ; Keshtgar MR
    Eur J Cancer; 2008 Sep; 44(13):1799-806. PubMed ID: 18614351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 17beta-hydroxysteroid dehydrogenases by phytoestrogens: comparison with other steroid metabolizing enzymes.
    Deluca D; Krazeisen A; Breitling R; Prehn C; Möller G; Adamski J
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):285-92. PubMed ID: 15860272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status.
    McCann SE; Kulkarni S; Trevisan M; Vito D; Nie J; Edge SB; Muti P; Freudenheim JL
    Breast Cancer Res Treat; 2006 Oct; 99(3):309-11. PubMed ID: 16541305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex steroid-producing enzymes in human breast cancer.
    Suzuki T; Miki Y; Nakamura Y; Moriya T; Ito K; Ohuchi N; Sasano H
    Endocr Relat Cancer; 2005 Dec; 12(4):701-20. PubMed ID: 16322318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer.
    Hedelin M; Bälter KA; Chang ET; Bellocco R; Klint A; Johansson JE; Wiklund F; Thellenberg-Karlsson C; Adami HO; Grönberg H
    Prostate; 2006 Oct; 66(14):1512-20. PubMed ID: 16921512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytoestrogens, novel dietary supplements for breast cancer.
    Huang S; Qi B; Yang L; Wang X; Huang J; Zhao Y; Hu Y; Xiao W
    Biomed Pharmacother; 2023 Apr; 160():114341. PubMed ID: 36753952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and validation of specific inhibitors of 17beta-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis.
    Day JM; Tutill HJ; Purohit A; Reed MJ
    Endocr Relat Cancer; 2008 Sep; 15(3):665-92. PubMed ID: 18541621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of phytoestrogen intake for breast cancer.
    Duffy C; Perez K; Partridge A
    CA Cancer J Clin; 2007; 57(5):260-77. PubMed ID: 17855484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestins and breast cancer.
    Pasqualini JR
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.